Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Karnon

Showing results (81-90 of 216) with videos related to

Pageof 22
Sort By:
Infection, Disease & Health|January 9, 2020
Estimating the utilisation of unregistered antimicrobials in AustraliaNadine T Hillock, Jonathan Karnon, John Turnidge, et al.
Plos One|March 24, 2022
Effect of a multi-faceted rapid response system re-design on repeat calling of the rapid response teamRichard Chalwin, Amy Salter, Jonathan Karnon, et al.
BMC Medical Education|July 14, 2011
Is different better?: models of teaching and their influence on the net financial outcome for general practice teaching postsCaroline O Laurence, Linda E Black, Carolyn Cheah, et al.
Cost Effectiveness and Resource Allocation : C/E|October 21, 2016
What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in AustraliaJonathan Karnon, Ainul Shakirah Shafie, Nneka Orji, et al.
Mental Health in Family Medicine|June 5, 2013
Evaluation of collaborative models of care in the management of patients with depression: protocol and progressHossein Haji Ali Afzali, Jonathan Karnon, Jodi Gray, et al.
BMJ Open|October 18, 2017
Sociodemographic variations in the amount, duration and cost of potentially preventable hospitalisation for chronic conditions among Aboriginal and non-Aboriginal Australians: a period prevalence study of linked public hospital dataDavid Banham, Tenglong Chen, Jonathan Karnon, et al.
Breast Cancer Research and Treatment|July 27, 2007
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspectiveThomas E Delea, Khalid El-Ouagari, Jonathan Karnon, et al.
International Journal of Technology Assessment in Health Care|January 18, 2021
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodiesHossein Haji Ali Afzali, Jackie Street, Tracy Merlin, et al.
Applied Health Economics and Health Policy|November 18, 2023
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?Jonathan Karnon, Andrew Partington, Jodi Gray, et al.
Applied Health Economics and Health Policy|April 4, 2022
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform PolicyNadine T Hillock, Tracy L Merlin, John Turnidge, et al.
Pageof 22

Showing results (81-90 of 216) with videos related to

Sort By:
Pageof 22
Infection, Disease & Health|January 9, 2020
Estimating the utilisation of unregistered antimicrobials in AustraliaNadine T Hillock, Jonathan Karnon, John Turnidge, et al.
Plos One|March 24, 2022
Effect of a multi-faceted rapid response system re-design on repeat calling of the rapid response teamRichard Chalwin, Amy Salter, Jonathan Karnon, et al.
BMC Medical Education|July 14, 2011
Is different better?: models of teaching and their influence on the net financial outcome for general practice teaching postsCaroline O Laurence, Linda E Black, Carolyn Cheah, et al.
Cost Effectiveness and Resource Allocation : C/E|October 21, 2016
What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in AustraliaJonathan Karnon, Ainul Shakirah Shafie, Nneka Orji, et al.
Mental Health in Family Medicine|June 5, 2013
Evaluation of collaborative models of care in the management of patients with depression: protocol and progressHossein Haji Ali Afzali, Jonathan Karnon, Jodi Gray, et al.
BMJ Open|October 18, 2017
Sociodemographic variations in the amount, duration and cost of potentially preventable hospitalisation for chronic conditions among Aboriginal and non-Aboriginal Australians: a period prevalence study of linked public hospital dataDavid Banham, Tenglong Chen, Jonathan Karnon, et al.
Breast Cancer Research and Treatment|July 27, 2007
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspectiveThomas E Delea, Khalid El-Ouagari, Jonathan Karnon, et al.
International Journal of Technology Assessment in Health Care|January 18, 2021
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodiesHossein Haji Ali Afzali, Jackie Street, Tracy Merlin, et al.
Applied Health Economics and Health Policy|November 18, 2023
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?Jonathan Karnon, Andrew Partington, Jodi Gray, et al.
Applied Health Economics and Health Policy|April 4, 2022
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform PolicyNadine T Hillock, Tracy L Merlin, John Turnidge, et al.
Pageof 22